Paul L Chariou

10PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyNanomedicineAgricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 11, 2023
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12.

S Elizabeth Franks, Ginette S Santiago-Sanchez, Kellsye P Fabian

|Jun 28, 2022
Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.

Christine M Minnar, Paul L Chariou, Lucas A Horn

|Aug 09, 2021
In situ vaccine application of inactivated CPMV nanoparticles for cancer immunotherapy.

Paul L Chariou, Veronique Beiss, Yifeng Ma

|Mar 04, 2020
Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients.

Paul L Chariou, Oscar A Ortega-Rivera, Nicole F Steinmetz

|May 22, 2019
Soil mobility of synthetic and virus-based model nanopesticides.

Paul L Chariou, Alan B Dogan, Alexandra G Welsh

Pageof 2